BackNemaura Medical Overview

Nemaura Medical Total Revenue

Latest total revenue for NMRD: $-1.6M, below the Healthcare sector average of $730B.

Get informed when a big investor buys or sells

+ Follow

Quarterly Revenue

N/A

As of Dec 2023

Annual Revenue (TTM)

$-1553436.00
↓ 490.98% YoY

Trailing 12 months ending Dec 2023

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading

Nemaura Medical (NMRD) FAQ

Nemaura Medical (NMRD) currently reports a total revenue of $-1.6M as of December 2023. That compares with $400K in the prior-year period — down 491.0% year over year. That is below the Healthcare sector average of $730B. Use the charts on this page to explore Nemaura Medical's total revenue history and peer comparisons.

Nemaura Medical's total revenue decreased from $400K to $-1.6M — a 491.0% year-over-year decrease (period ending December 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Nemaura Medical's total revenue of $-1.6M is lower than the Healthcare sector average of $730B. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Nemaura Medical reported $-1.6M in total revenue as of December 2023. That compares with $400K in the prior-year period — down 491.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total revenue of $-1.6M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $730B. From there, open related valuation or income-statement pages for Nemaura Medical, and consider following NMRD for alerts when major investors trade the stock.